Poster Abstract Session:
231. Clostridium difficile: Outcomes, Testing, Prevention
Saturday, October 29, 2016: 12:30 PM-2:00 PM
Room: Poster Hall

Learning Objectives:

.

Tracks: Epidemiology and Infection Control, Adult ID

Presentations:
Hospital readmissions related to Clostridium difficile infection
Abhishek Deshpande, MD, PhD ; Chaitanya Pant, MD ; Mojtaba Olyaee, MD ; Curtis J. Donskey, MD
Infrequent Skin Contamination with Clostridium difficile Spores Among Oncology Patients on Units with a High Incidence of C. difficile Colonization
Shela Sridhar, MD ; Curtis J. Donskey, MD ; Nathan Ledeboer, PhD, D(ABMM) ; Nicholas Yunker, - ; Tami Mackey, MT(ASCP) ; Mary Beth Graham, MD, FIDSA ; April Vanderslik, RN, BSN, CIC ; Laura Michaelis, MD ; Parameswaran Hari, MD ; L. Silvia Munoz-Price, MD, PhD
Real-Time Clinical Data Tracking Enables Enforcement of Diarrhea and Absence of Laxatives in Hospitalized Patients Undergoing Clostridium difficile Testing
Cynthia Truong, BS ; Lee Schroeder, MD, PhD ; Marisa Holubar, MD, MS ; John Shepard, BA, MBA, MHA ; Alexandra Madison, BS, BA, MPH ; Lucy Tompkins, MD, PhD, FSHEA, FIDSA ; Neil Shah, MD ; Niaz Banaei, MD
Implication of Clostridium difficile Strain Typing in Recurrent C. difficile Infection
Donna Schora, MT(ASCP) ; Sanchita Das, MD ; Becky Smith, MD ; James Boone, MS ; Robert Carman, PhD ; Lance Peterson, MD, FIDSA, FSHEA
Effect of an Electronic Hard-Stop Intervention to Prevent Repeat Clostridium difficile Toxin Testing on Test Utilization and Clinical Outcomes
Jennie H. Kwon, DO, MSCI ; Kimberly Reske, MPH ; Tiffany Hink, BS ; Ronald Jackups Jr., MD ; Carey-Ann D. Burnham, PhD ; Erik R. Dubberke, MD, MSPH, FIDSA, FSHEA
Detection and Infection Prevention Differs between Community Onset (CO) and Hospital Onset (HO) Clostridium difficile Cases
J Bradford Bertumen, MD ; Christopher W Woods, MD, MPH, FIDSA ; Susan Wilkins, BS, MDiv ; Lawrence Park, PhD
Posters
  • ID Week poster (2).pdf (429.2 kB)
  • Performance of Published Clostridium difficile Severity Scoring Systems in an External Cohort
    Daniel Mcclung, MD ; Krishna Rao, MD, MS ; Peter D. R. Higgins, MD, PhD ; Vincent B. Young, MD, PhD, FIDSA
    The Impact of Laxative Use on Hospital Onset Clostridium Difficile Diarrhea
    Saritha Gomadam, D.O ; Moises Huaman, MD, MSc ; Tigre Suder, RN, BSN ; Derek Forster, MD
    Transfer of Bacteriophage MS2 versus Clostridium difficile Spores to Environmental Surfaces during Simulations of Patient Care
    Heba Alhmidi, MD ; Sreelatha Koganti, MD ; Myreen Tomas, MD ; Jennifer L. Cadnum, BS ; Annette Jencson, BSMT(ASCP)SM, CIC ; Thriveen Mana, M.S., MBA ; Curtis J. Donskey, MD
    Estimating local attributable cost of Clostridium difficile infection using electronic medical record data
    Theodore Pak, AB ; Kieran Chacko, BA, BS ; Timothy O'donnell, BSc ; Shirish Huprikar, MD ; Harm Van Bakel, PhD ; Andrew Kasarskis, PhD ; Erick Scott, MD, MHS
    Clostridium Difficile, Evaluation of Testing Practices, non C. Difficile Antibiotic Use and Implications for the Clinical Practice
    Victor Cepeda, MD ; Prakash Shrestha, MD ; Kelly Echevarria, Pharm.D,.BCPS, AQ-ID ; Courtney Ortiz, Pharm.D., BCPS ; Hilda Ben, BSN, RN, CIC ; Jose Cadena, MD/ID
    Reducing Unnecessary Clostridium difficile Testing in a Community Teaching Hospital
    Uri Goldberg, MD ; Alok Gupta, MD ; Virginie Auguste, MD ; Jorge Donado, MD ; Vincent Peyko, Pharm.D ; Angela Belfer, RN ; Pwint Htwe, MD ; Rajat Mukherji, MD
    Initiation of a Performance Review Committee (PRC) with Multi-Disciplinary Healthcare Team Members and the Impact on Hospital-Acquired Clostridium difficile Infection (CDI)
    Kristie Zappas, PharmD, BCPS (AQ-ID) ; James Mcclelland, MD ; Kerry Schwartz, MD, FACC, FACP ; Jason Price, MBA, MSN, RN ; Cathy Stankiewicz, MSN, RN, CPHQ ; Alba Cruz-Betancourt, MSN, RN, CCNS ; Hermanda Milton, MSN/Ed ; Patrice Berwager, MSN, RN, CEN ; Kurry Lewis, RN ; Julie Hess, MT(ASCP) ; Brian Jones, BS
    Impact of the BioFire® FilmArray Gastrointestinal Panel in Children Hospitalized for Acute Gastroenteritis
    Jennifer Dien Bard, Ph.D ; Ara Festekjian, MD ; Chris Stockmann, PhD, MSc ; Daniel Cohen, MD ; Amy Leber, PhD ; Judy Daly, PhD ; Jami Jackson, DO ; Rangaraj Selvarangan, PhD ; Neena Kanwar, PhD ; Susan Duffy, MD ; Kristen Holmberg, PhD ; Kevin Bourzac, PhD ; Kimberle C. Chapin, MD ; Andrew Pavia, MD, FIDSA, FSHEA, FPIDS ; Jeffery Bender, MD
    Posters
  • BioFire IDWeek poster.pdf (386.6 kB)
  • CME Credits: No CME credit is offered for this session.

    ACPE Credits:

    ACPE Number:


    Findings in the abstracts are embargoed until 12:01 a.m. CDT, Wednesday Oct. 26th with the exception of research findings presented at the IDWeek press conferences.